Running clinical lab tests is a labour-intensive business. Even if the actual test is done by an automated platform, many stages still require manual handling of the specimens, which can limit throughput and allow the potential for errors to occur (we’re only human, after all!). Increasing the amount of automation circumvent these limitations and CLI […]
By Serena Shell, Bheemraj Ramoo, C. Clinton Frazee III and Prof. Uttam Garg Mycophenolic acid is an immunosuppressant administered to patients undergoing various organ transplants. Therapeutic drug monitoring of mycophenolic acid is important to reduce drug toxicity and organ rejection. This is accomplished using several techniques including immunoassays, high-performance liquid chromatography with an ultraviolet detector […]
By Dr Laura M. Labay and Dr Sherri L. Kacinko The forever contaminants of our generation PFAS (perfluoroalkyl and polyfluoroalkyl substances) are synthetic chemicals that have a wide range of industrial and manufacturing applications because of their chemical and thermal stability and their hydrophobic and lipophobic characteristics. PFAS are persistent in the environment, bioaccumulate in […]
By Dr Jacqueline Gosink Autoimmune neurology is a rapidly growing field driven by the ongoing discovery of novel neural autoantibodies associated with recognizable clinical syndromes. These diseases can affect the central, peripheral and autonomic nervous systems and may co-occur with cancer. Today’s testing landscape encompasses more than 60 neural autoantibodies targeting different intracellular proteins, receptors […]
By Dr F. van Delft, Dr M. Schuurbiers, Dr van den Heuvel and Dr H. van Rossum The development of immunotherapy and other targeted therapies has given rise to significant improvements in the treatment of non-small cell lung cancer. However, some patients do not benefit from these therapies and it is, therefore, important for a […]
We all know that detecting cancer early is the key to obtaining the best treatment outcomes. However, how do you do this when some sectors of the population struggle to access healthcare and does point-of care testing make it possible to take health screening to the people who need it? CLI caught up with Professor […]
Although the prevalence of ovarian cancer is fairly low, it is often asymptomatic until after metastasis, resulting in it being the fourth leading cause of cancer death in females in the USA. The development of biomarker screening tests for ovarian cancer has been challenging and the situation is still not satisfactory. Additionally, the tests that […]
By Dr Reinhold Wimberger-Friedl Analysis of tumour tissue for molecular biomarkers is a labour-intensive and time-consuming process, requiring precision at each of the many steps involved. This article discusses how recently launched technology is helping to improve sample selection and tissue dissection.
By Rosa Ferrer, Andrea Mansilla and Maria Costa The role of human chorionic gonadotropin in pregnancy has been extensively studied for many years. However, the importance of this hormone goes beyond pregnancy. It can also be used as a biomarker, mainly in trophoblastic tumours, but as will be shown later in this article, its importance […]
Attend the Innovation Days in Biology (JIB) and stay connected to the scientific, technical, professional and organizational developments of medical biology. Medical biology is essential to the health of our fellow citizens, from diagnosis to treatment and follow-up, scientists are continually looking for innovation. There are many hot topics expected at the event in Paris […]
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
